Why Radius Health Inc. (NASDAQ:RDUS) Stock Increased 21.66 percent in recent Trade?

BofA Securities raised the price target for the Radius Health Inc. (NASDAQ:RDUS) stock from ‘an Underperform’ to ‘a Neutral’. The rating was released on June 08, 2023, according to finviz. The research report from Morgan Stanley has downgraded the stock from Equal-Weight to Underweight, with a price target set at $7. The stock was downgraded by Goldman, who disclosed in a research note on December 10, 2021, from Buy to Neutral and set the price objective to $12. In their research brief published December 03, 2021, BofA Securities analysts initiated the Radius Health Inc.